SEC Company Response from Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989) (OTLK) — May 2, 2024
Outlook Therapeutics, Inc. (OTLK) (CIK 0001649989)
Date: May 2, 2024 · CIK: 0001649989 · Accession: 0001104659-24-056164
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278959
Letter
OUTLOOK THERAPEUTICS, INC.
111 S. Wood Avenue
Unit #100
Iselin, New Jersey 08830
(609) 619-3990
May 2, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Outlook Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 26, 2024
File No. 333-278959
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-278959) (the “Registration Statement”) to become effective on Monday, May 6, 2024, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, at (212) 479-6721, or in his absence Courtney Tygesson of Cooley LLP at (312) 881-6680.
Very truly yours,
OUTLOOK THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
OUTLOOK THERAPEUTICS, INC.
111 S. Wood Avenue
Unit #100
Iselin, New Jersey 08830
(609) 619-3990
May 2, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Outlook Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 26, 2024
File No. 333-278959
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended,
the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the
“Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-278959)
(the “Registration Statement”) to become effective on Monday, May 6, 2024, at 4:00 p.m., Eastern Time, or as
soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission
(the “Staff”). The Registrant hereby authorizes Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant,
to make such request on its behalf.
Once the Registration Statement has been declared effective, please
orally confirm that event with Yvan-Claude Pierre of Cooley LLP, counsel to the Registrant, at (212) 479-6721, or in his absence Courtney
Tygesson of Cooley LLP at (312) 881-6680.
Very truly yours,
OUTLOOK THERAPEUTICS, INC.
By:
/s/ Lawrence A. Kenyon
Name: Lawrence A. Kenyon
Title: Chief Financial Officer, Treasurer and Secretary
cc: Yvan-Claude Pierre, Cooley LLP
Courtney Tygesson,
Cooley LLP